Blood Collection Biorepository for Liver Disease Research
State University of New York at Buffalo · NCT03025074
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 7+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 1000
- US sites recruiting
- 1
- Study start
- July 2013
- Record last updated
- October 8, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The purpose of establishing a biorepository is to provide high quality specimens (serum, plasma, buffy coat and liver tissue) for future researchers who are studying the effects that fatty liver and viral diseases have on the liver.
Conditions: Non-Alcoholic Steatohepatitis(NASH); Hepatitis C; Hepatitis B; Fibrosis; Cirrhosis; Fatty Liver; Obesity, Childhood; Bariatric Surgery Candidate
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- This protocol is to establish a biobank of blood samples from individuals with or without liver diseases including viral hepatitis, liver cancer, NASH, and negative control samples.
- Children and teenagers will be special populations considered in this protocol.
Exclusion Criteria
- Vulnerable populations such as adults unable to consent, infants, pregnant women or prisoners will not be considered for this research study.
Recruiting US locations
University at Buffalo, Buffalo General Medical Center
Buffalo, NY 14203
Site contact: Barbara Bauer, BA · 716-888-4825 · bmbauer@buffalo.edu
Study contacts (from the official record)
- Barbara Bauer, BA · 716-888-4825 · bmbauer@buffalo.edu
Similar studies in New York
All weight loss studies in New York →- RecruitingHealthy volunteersPhase 1
Alpelisib Challenge Test (ACT)
Columbia University
- Location
- New York, NY
- Eligibility basics
- Ages 18–70
- RecruitingHealthy volunteersPhase 1
Human Models of Selective Insulin Resistance: Alpelisib, Part I
Columbia University
- Location
- New York, NY
- Eligibility basics
- Ages 18–70
- RecruitingHealthy volunteersPhase 3
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
- Location
- The Bronx, NY + 55 other US sites
- Eligibility basics
- Ages 18–79
- RecruitingHealthy volunteers
Hunger Perception and Weight-Related Outcomes Following Use of a Leptin-Supporting Dietary Supplement
Efforia, Inc
- Location
- New York, NY
- Eligibility basics
- Ages 18+